TEVAR procedure performed by cardiologists saves elderly man in Madurai hospital

A 70-year-old man, who was suffering from a life threatening bulge in the major artery of his chest - a thoracic aortic aneurysm - was successfully treated by a team of surgeons at the Meenakshi Super Speciality Hospital.
Addressing a press conference here on Wednesday, cardiologist Sivakumar and team members said that the patient was in cardiogenic shock, a critical condition where the heart is unable to pump enough blood. A CT aortogram revealed that the aneurysm had ruptured into the oesophagus, making the situation extremely grave, he said.
The doctors performed a minimally invasive procedure called Thoracic Endovascular Aortic Repair (TEVAR), placing a stent graft inside the damaged artery through a small puncture in the leg. The rupture was immediately sealed, leading to a remarkable recovery. The patient's blood pressure and kidney function improved significantly, and he was discharged with medication and is now doing well under close follow-up.
In another patient, using the Transcatheter Aortic Valve Replacement (TAVR), a non-surgical method of replacing a severely narrowed aortic valve through a catheter-based approach, the team of surgeons successfully treated a 68-year-old man.
The patient had severe narrowing of the aortic valve (aortic stenosis) and was admitted with congestive cardiac failure (CCF). He had biventricular dysfunction with a reduced heart pumping capacity (ejection fraction of 35%), kidney failure (AKI), ascites, and pulmonary hypertension.
After evaluation and stabilisation with dialysis, the team performed TAVR, replacing the diseased valve through a small puncture in the groin. Once the new valve began to function, the patient showed rapid improvement in heart and kidney function. His liver condition also began to stabilise, and he was discharged in a stable condition.
In recent times, the hospital had successfully performed Transcatheter Edge-to-Edge Repair (TEER), a technique that clips the leaking mitral valve to reduce mitral regurgitation without the need for open-heart surgery, for a 41-year-old male, Dr. Sivakumar added.
Before the advent of structural interventions, surgeons had to do open-heart surgery, stopping the heart, and using a heart-lung machine to fix or replace valves or walls. Recovery was long and riskier. Today, these advances allow surgeons to treat heart problems through blood vessels using advanced imaging and tiny tools. The procedures offer faster recovery, less pain and new hope for elderly or high-risk patients who couldn't undergo traditional surgery.
These high-risk structural interventions were performed by a multidisciplinary team including S. Selvamani, N. Ganesan, M. Sampath Kumar, Jeyapandiyan, Thomas Xavier, S. Kumar, R.M. Krishnan, Rajan, and Prabhu Kumarappan Chidambaram.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Hans India

2 days ago

• Hans India

Meril Launches MyClip, India's First Transcatheter-Edge-to-Edge Repair (TEER) System for Treatment of Severe Mitral Regurgitation

Meril Life Sciences, a leading global med-tech company, marked a significant milestone with the launch of MyClip, India's first Transcatheter Edge-To-Edge Repair (TEER) system, on June 14. The landmark Structural Heart Innovation event, held at Meril Academy, Vapi (Gujarat) from June 13–15, brought together over 150 Indian interventional cardiologists along with cardiac imaging expert and international stalwarts, including Prof. Ottavio Alfieri ('Father of mitral valve repair'), Prof. Francesco Maisano, and Prof. Agricola, joining global pioneers in edge-to-edge mitral valve repair. Meril is currently the world's leading TAVI group following the success of Myval THV and first Indian company to introduce a TEER system, placing the country firmly on the map as an innovator in transcatheter heart valve therapies (with both replacement and repair technology platforms). MyClip introduction demonstrates India's growing capabilities in structural heart solutions and reflects Meril's commitment to accessible cutting-edge cardiac care. MyClip TEER System is designed for patients suffering from severe Mitral Regurgitation (MR) who are at high surgical risk due to pre-existing issues like hypertension, diabetes, obesity, advanced age, physical frailty, enlarged or weak heart, and patients with kidney, lung and liver problems. MR, particularly if untreated, has a devastating mortality rate—over 50% of patients may not survive without timely intervention, and 1-year mortality can be as high as 57%. The MyClip TEER System enables precise closure of the mitral valve flaps, effectively preventing the backward flow of purified blood into the lungs. The procedure is minimally invasive, & takes approximately one hour, and allows patients to return home within 3–5 days. After discharge, patients can resume daily activities like walking and non-strenuous work within a short period post the procedure. According to the landmark COAPT Study published in the New England Journal of Medicine (NEJM), patients receiving device-based therapy for mitral regurgitation experienced significantly better outcomes compared to those receiving standard medical treatment. Within 24 months, the hospitalization rate for heart failure was reduced to 35.8% per patient-year in the device group, compared to 67.9% in the control group. Additionally, mortality within the same period was notably lower in the device group, at 29.1%, compared to 46.1% in the control group. Currently, approximately 150 TEER (Transcatheter Edge-to-Edge Repair) procedures are performed annually in India, with the majority of patients falling in the younger age group (30 – 60). These statistics bring to light a pressing need for early and effective intervention in younger demographics. The launch of MyClip TEER System marks a transformative moment for structural heart therapy in India. Transcatheter Edge-to-Edge Repair (TEER) therapy has shown significant success over traditional Guideline Directed Medical Therapy (GDMT). MyClip represents a major step forward in India's cardiovascular treatment landscape. In his inaugural speech, Sanjeev Bhatt, Senior Vice President of Corporate Strategy at Meril Life Sciences, said, 'In India, around 1.5 million people are known to have severe mitral regurgitation. Of these at least 1.2 million are post myocardial infarction (MI or a heart attack) or due to heart failure. Introduction of the MyClip TEER system marks a pivotal shift and we're witnessing early adoption. Meril's efforts in training cardiologists and building TEE-based imaging expertise are crucial steps in scaling this life-saving therapy across the country." 'With MyClip, Meril is reshaping the country's role in global medtech. This homegrown innovation is a testament to what Indian science, engineering, and clinical collaboration can achieve together. Meril's nationwide public awareness campaign #TreatmentZarooriHai is in full swing, with brand ambassador MS Dhoni, to educate patients and families about the life-saving value of timely intervention in mitral valve regurgitation,' Bhatt added. The two-day Structural Heart Innovation scientific program featured case demonstrations, interactive hands-on workshops, and the presentations leading Interventional Cardiologists and Echocardiologists. The event concluded with a call to build a sustainable M-TEER ecosystem in India, focused on accessibility, clinical excellence, and continuous innovation.

The Hindu

3 days ago

• The Hindu

TEVAR procedure performed by cardiologists saves elderly man in Madurai hospital

A 70-year-old man, who was suffering from a life threatening bulge in the major artery of his chest - a thoracic aortic aneurysm - was successfully treated by a team of surgeons at the Meenakshi Super Speciality Hospital. Addressing a press conference here on Wednesday, cardiologist Sivakumar and team members said that the patient was in cardiogenic shock, a critical condition where the heart is unable to pump enough blood. A CT aortogram revealed that the aneurysm had ruptured into the oesophagus, making the situation extremely grave, he said. The doctors performed a minimally invasive procedure called Thoracic Endovascular Aortic Repair (TEVAR), placing a stent graft inside the damaged artery through a small puncture in the leg. The rupture was immediately sealed, leading to a remarkable recovery. The patient's blood pressure and kidney function improved significantly, and he was discharged with medication and is now doing well under close follow-up. In another patient, using the Transcatheter Aortic Valve Replacement (TAVR), a non-surgical method of replacing a severely narrowed aortic valve through a catheter-based approach, the team of surgeons successfully treated a 68-year-old man. The patient had severe narrowing of the aortic valve (aortic stenosis) and was admitted with congestive cardiac failure (CCF). He had biventricular dysfunction with a reduced heart pumping capacity (ejection fraction of 35%), kidney failure (AKI), ascites, and pulmonary hypertension. After evaluation and stabilisation with dialysis, the team performed TAVR, replacing the diseased valve through a small puncture in the groin. Once the new valve began to function, the patient showed rapid improvement in heart and kidney function. His liver condition also began to stabilise, and he was discharged in a stable condition. In recent times, the hospital had successfully performed Transcatheter Edge-to-Edge Repair (TEER), a technique that clips the leaking mitral valve to reduce mitral regurgitation without the need for open-heart surgery, for a 41-year-old male, Dr. Sivakumar added. Before the advent of structural interventions, surgeons had to do open-heart surgery, stopping the heart, and using a heart-lung machine to fix or replace valves or walls. Recovery was long and riskier. Today, these advances allow surgeons to treat heart problems through blood vessels using advanced imaging and tiny tools. The procedures offer faster recovery, less pain and new hope for elderly or high-risk patients who couldn't undergo traditional surgery. These high-risk structural interventions were performed by a multidisciplinary team including S. Selvamani, N. Ganesan, M. Sampath Kumar, Jeyapandiyan, Thomas Xavier, S. Kumar, R.M. Krishnan, Rajan, and Prabhu Kumarappan Chidambaram.

Hans India

6 days ago

• Hans India

Campaign launched to combat male infertility

Hyderabad: Oasis Fertility has launched a unique initiative, 'Happy Father's-To-Be Day' to celebrate the spirit of Fatherhood with a theme, 'Healthy Man, Father'. The event was inaugurated by the Chief Guest A Ramulu, Additional DCP, Hyderabad Traffic Police alongside Dr Krishna Chaitanya M, Scientific Head and Clinical Embryologist, Oasis Fertility, and other dignitaries. In this regard, under the empowering theme 'Healthy Man, Happy Father', Oasis Fertility celebrates the journey of men aspiring to fatherhood through its campaign. This initiative is a step toward breaking the silence around male infertility, challenging long-held stigmas, and ensuring men have access to personalised, research-driven fertility treatments. As part of the initiative, Oasis Fertility offered free semen analysis for traffic police personnel, along with free fertility screening assessments across all its centres in Telangana on the June 14.